BUU-32455-81927
2 vaccinations
1 coded response
4 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 288 / NC
- Registered
- 2021-06-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-13
Dose 1 — Pfizer-BioNTech
-
2021-06-03
Dose 2 — Pfizer-BioNTech
-
2021-06-11
Registered in v-safe
- 2021-06-11
- 2021-06-17
- 2021-06-24
-
2021-07-08
Survey response — day 35, dose 2MedDRA: Cough, Malaise, Nasal congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Dry, mostly unproductive cough and stuffy nose. General malaise.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-08
Report sent to call center — day 35, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-13 | Pfizer-BioNTech | |
| 2 | 2021-06-03 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — day 35, dose 2
Symptoms: Dry, mostly unproductive cough and stuffy nose. General malaise.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release